TechFlame reports that NASDAQ plans to delist BNB treasury company Windtree Therapeutics (stock code: WINT) because the company failed to comply with NASDAQ listing rule 5550 (a) (2) — that is, the minimum bid for shares must be kept above $1. Windtree confirmed its non-compliance status in a filing with the US Securities Regulatory Commission.